News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
310 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39122)
2019 (51337)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42567)
2024 (37443)
2025 (33092)
2026 (3814)
Month
January (2936)
February (2969)
March (2710)
April (2908)
May (3626)
June (2409)
July (2088)
August (2590)
September (2381)
October (3064)
November (3189)
December (2222)
Day
1 (184)
2 (142)
5 (163)
6 (107)
7 (310)
8 (241)
9 (171)
12 (212)
13 (134)
14 (258)
15 (266)
16 (111)
19 (118)
20 (145)
21 (149)
22 (140)
23 (132)
26 (20)
27 (147)
28 (183)
29 (187)
30 (105)
31 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
5
6
7
8
9
12
13
14
15
16
19
20
21
22
23
26
27
28
29
30
31
Press Releases
European Commission approves TREMFYA® (guselkumab), the first dual-acting IL-23 inhibitor offering both subcutaneous and intravenous induction options, for adult patients with moderately to severely active Crohn’s disease
May 7, 2025
·
18 min read
Press Releases
Bulletin from the Annual General Meeting in Alligator Bioscience AB on 7 May 2025
May 7, 2025
·
4 min read
Press Releases
AACR 2025: Brenus Pharma Presents Late-breaking Preclinical Data on its “off-the-shelf” Next-generation Vaccine-based Immunotherapy Candidate, STC-1010, Now Moving to Clinic
May 7, 2025
·
2 min read
Press Releases
LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy
May 7, 2025
·
6 min read
Press Releases
BeiGene Announces First Quarter 2025 Financial Results and Business Updates
May 7, 2025
·
20 min read
Press Releases
The Caris Precision Oncology Alliance Welcomes LSU LCMC Health Cancer Center
May 7, 2025
·
4 min read
Press Releases
Merck to Participate in the Bank of America 2025 Global Healthcare Conference
May 7, 2025
·
3 min read
Press Releases
Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025
May 7, 2025
·
29 min read
Press Releases
Spectral Medical Announces Non-Dilutive Financing of Up to $10 Million with Vantive
May 7, 2025
·
4 min read
Press Releases
Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting
May 7, 2025
·
6 min read
Previous
19 of 31
Next
